Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin regimens for pain and inflammation after impacted lower third molar extraction
ACTRN12624001414505Phase 4Not yet recruiting
- Sponsor
- Universidad de Granada
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of amoxicillin in Impacted lower third molar (4 arms), sponsored by Universidad de Granada. Primary endpoints: Pain and Trismus. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
amoxicillin
03
Conditions
Impacted lower third molar
Beyond the preview
Go deeper on ACTRN12624001414505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001414505.